Alligator Bioscience

Company Description

---

Alligator develops antibody-based pharmaceuticals for cancer treatment. The company specializes in the development of tumor-directed immunotherapies, in particular agonistic mono- and bispecific antibodies. The company is active in the early stages of drug development, from idea to clinical phase 2 studies and beyond.

Alligator Bioscience has global headquarters in Lund, Sweden, and is listed on Nasdaq Stockholm (ticker: ATORX).

Year founded

---

2001

Served area

---

Worldwide

Headquarters

---

Scheelevägen 2, 22381 Lund – Sweden

Shares outstanding

---

221,534,728

IPO

---

Jan. 1, 2000

Stock exchange(s)

---

Nasdaq Stockholm